Background: The eye and the skin share embryological origin and immunological pathways, and a wide range of dermatological disorders produce recognisable ocular signs. Awareness of these associations allows earlier diagnosis and appropriately shared care between dermatologists and ophthalmologists. Purpose: To narratively review the ocular manifestations of four common dermatoses — psoriasis, atopic dermatitis, rosacea, and pemphigus vulgaris — and to place the available evidence in the context of Indian dermato-ophthalmic practice, where disease patterns, treatment access, and follow-up infrastructure differ from those in the Western literature this evidence base largely derives from. Methods: A narrative synthesis of the published literature (PubMed/MEDLINE-indexed reviews, systematic reviews, cohort studies, and Indian case series) on ocular involvement in psoriasis, atopic dermatitis, rosacea, and pemphigus vulgaris, supplemented by Indian dermato-ophthalmology outpatient studies where available. Findings: Across all four conditions, ocular surface inflammation — blepharitis, conjunctivitis, meibomian gland dysfunction, and dry eye disease — is the most frequently reported finding. More severe, sight-threatening involvement (keratitis, uveitis, cicatricial conjunctival disease) occurs less often but carries greater morbidity, particularly in rosacea keratitis and pemphigus-related cicatrisation. In atopic dermatitis, biologic therapy (dupilumab) has introduced a distinct iatrogenic conjunctivitis that must be distinguished from disease-driven ocular surface inflammation. Indian outpatient data suggest atopic dermatitis, herpes zoster ophthalmicus, and psoriasis are among the leading dermatology-referred causes of ocular morbidity seen in ophthalmology clinics. Conclusion: Ocular involvement in dermatological disease is common, frequently under-recognised, and often treatable. Structured referral pathways between dermatology and ophthalmology — feasible even within India's tertiary and district-hospital network — can reduce diagnostic delay and preventable ocular morbidity.